Treatment and rehabilitation of Long COVID: A scope of the literature.:Update January 2023

Summary • We identified 12 randomised controlled trials published since September 2022 that were focused on Long COVID treatment or rehabilitation. Across our three reports produced to date, we have identified and assessed 37 trials published between January and December 2022. • Half of the trials included in this update had a primary focus on treating persistent problems with respiratory function and physical fitness (n=6). Other trials focused on olfactory dysfunction (n=2); and cognitive problems and long-term fatigue (n=1). Three trials evaluated non-specific interventions for treating Long COVID symptoms (n=3). • Seven trials were rated positively for at least 11 out of the 13 criteria that we assessed.